Research update- March 2022
In 2022 we are aiming to improve and increase patient representation in neuroblastoma research. This spotlight on research advocacy explains exactly what that means and how we will achieve it.
Relapse prevention therapies: an in-depth look
In this special edition of our research blog, Research Director and Chair of Trustees, Nick Bird, looks at the landscape of maintenance therapies and their accessibility in the UK.
Neuroblastoma Parent Global Symposium 2021- A round-up
Read the highlights of our second virtual parent conference hosted with Solving Kids' Cancer Us and the Children's Neuroblastoma Cancer Foundation.
Research update- December 2021
Heading into Winter, we have lots of exciting updates from the Research team at Solving Kids' Cancer.
Behind the research: Felix's incredible legacy
After losing his battle with neuroblastoma aged 6, Felix left an incredible legacy which will help countless children just like him.
Research update- September 2021
The summer months are always busy here for team SKC with lots of exciting things around the corner in Autumn to prepare for.
Research explainer: How do ALK gene alterations affect the clinical outcome for patients with high-risk neuroblastoma?
Find out more about the latest breakthrough from researchers across Europe on the significance of ALK gene alterations in high-risk neuroblastoma.
An AMRC member charity: What does it mean?
In 2018, we announced our awarded membership to the Association of Medical Research Charities (AMRC), but what does this actually mean for our research?
Research update- June 2021
The Spring months have been as busy as ever for our research team, with the announcement of our latest project as well as progress reviews for our ongoing work and looking ahead at the SKC research strategy for the coming years.
